News from eli lilly and company

Jul 10, 2014, 13:00 ET
Eli Lilly and Company logo. (PRNewsFoto, Eli Lilly and Company)

Lilly for Better Health™ expands website's non-product-branded health education resources, focuses on healthy behavior skills

 Eli Lilly and Company (NYSE: LLY) has rebooted the Lilly for Better Health™ program, with several innovative enhancements to...

Jul 10, 2014, 13:00 ET
Jul 09, 2014, 12:00 ET
Eli Lilly and Company logo. (PRNewsFoto, Eli Lilly and Company)

Lilly Confirms Date and Conference Call for Second-Quarter 2014 Financial Results Announcement

 Eli Lilly and Company (NYSE: LLY) will announce its financial results for the second quarter of 2014 on Thursday, July 24, 2014.  Lilly...

Jul 08, 2014, 08:00 ET
Eli Lilly and Company logo. (PRNewsFoto, Eli Lilly and Company)

Lilly to Showcase Data from its Alzheimer's Disease Portfolio at the Alzheimer's Association International Conference 2014 (AAIC 2014)

 Eli Lilly and Company (NYSE: LLY) today announced that 23 presentations will be given at the Alzheimer's Association International Conference...

Jul 07, 2014, 16:35 ET
Ryan Reed (PRNewsFoto/Eli Lilly and Company)

NASCAR Driver Ryan Reed Finishes Fourth at the Subway Firecracker 250 at Daytona International Speedway

News Highlights: - #DiabetesChamp & Lilly #Diabetes ambassador @driverRyanReed finishes 4th at the Subway Firecracker 250 -...

Jun 27, 2014, 08:00 ET
Eli Lilly and Company logo. (PRNewsFoto, Eli Lilly and Company)

CHMP Recommends Lilly and Boehringer Ingelheim's Investigational New Insulin Glargine Product for Approval in the European Union

 The Committee for Medicinal Products for Human Use (CHMP) today issued a positive opinion recommending approval for the investigational...

Jun 27, 2014, 08:00 ET
Eli Lilly and Company logo. (PRNewsFoto, Eli Lilly and Company)

CHMP Recommends Lilly and Boehringer Ingelheim's New Insulin Glargine Product for Approval in the European Union

The Committee for Medicinal Products for Human Use (CHMP) today issued a positive opinion recommending approval for the investigational compound...

Jun 25, 2014, 09:00 ET
Lilly Diabetes Logo.  (PRNewsFoto/Eli Lilly and Company)

Diabetes Scholars Foundation Announces 2014 Scholarship Recipients

Managing a chronic disease like type 1 diabetes can be difficult for a person of any age, but can be especially daunting while navigating the halls...

Jun 23, 2014, 08:00 ET
Eli Lilly and Company logo. (PRNewsFoto, Eli Lilly and Company)

Eli Lilly and Company Collaborates with Public and Private Healthcare Organizations to Provide Medical Students an Opportunity to Explore Healthcare Outside the Traditional Learning Environment

Students from Marian University College of Osteopathic Medicine are onsite at Eli Lilly and Company (NYSE: LLY) corporate headquarters in...

Jun 17, 2014, 15:53 ET
Eli Lilly and Company logo. (PRNewsFoto, Eli Lilly and Company)

Type 2 diabetes: Boehringer Ingelheim and Eli Lilly and Company announce resubmission of New Drug Application for empagliflozin to FDA

 Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) and Eli Lilly and Company (NYSE: LLY) today announced the resubmission of a New Drug...

Jun 16, 2014, 18:15 ET
Eli Lilly and Company logo. (PRNewsFoto, Eli Lilly and Company)

Lilly Announces Detailed Results from Two Phase III Studies Testing Both Doses of Dulaglutide vs. Insulin Glargine

Eli Lilly and Company (NYSE: LLY) today released detailed results from two AWARD trials that showed treatment with once-weekly dulaglutide 1.5 mg...

Jun 16, 2014, 14:15 ET
Eli Lilly and Company logo. (PRNewsFoto, Eli Lilly and Company)

Lilly Declares Third-Quarter 2014 Dividend

The board of directors of Eli Lilly and Company (NYSE: LLY) has declared a dividend for the third quarter of 2014 of $0.49 per share on...

Jun 16, 2014, 11:45 ET
Boehringer Ingelheim logo.  (PRNewsFoto/Eli Lilly and Company)

Type 2 diabetes: Investigational compound empagliflozin as an add-on therapy significantly reduced blood glucose and body weight in two newly presented phase III trials

Two phase III clinical trials studying the efficacy and safety of the investigational compound empagliflozin in type 2 diabetes (T2D) were...

Jun 15, 2014, 15:00 ET
Eli Lilly and Company logo. (PRNewsFoto, Eli Lilly and Company)

Type 2 Diabetes: Investigational Empagliflozin/Linagliptin Combination Tablet Showed Reduction in Blood Glucose in Two Phase III Trials

 Two phase III clinical trials found  the investigational combination tablet of empagliflozin and linagliptin reduced blood glucose levels...

Jun 14, 2014, 13:00 ET
Eli Lilly and Company logo. (PRNewsFoto, Eli Lilly and Company)

Studies Show Investigational New Insulin Glargine Product from Lilly and Boehringer Ingelheim Similar Safety and Efficacy Profile to Lantus®

For the first time today, Eli Lilly and Company (NYSE:LLY) and Boehringer Ingelheim Pharmaceuticals Inc. presented data showing that LY2963016, the...

Jun 14, 2014, 13:00 ET
Eli Lilly and Company logo. (PRNewsFoto, Eli Lilly and Company)

Lilly's Basal Insulin Peglispro Shows Novel Mechanism of Action

Eli Lilly and Company (NYSE: LLY) today announced new data regarding the mechanism of action of basal insulin peglispro (BIL). When BIL and insulin...

Jun 14, 2014, 13:00 ET
Eli Lilly and Company logo. (PRNewsFoto, Eli Lilly and Company)

Lilly's Once-Weekly Dulaglutide Shows Similar Reductions in Average Blood Glucose Levels as Once-Daily Liraglutide in Head-to-Head Trial

 Eli Lilly and Company (NYSE: LLY) today released detailed results from dulaglutide's sixth AWARD trial, showing that once-weekly dulaglutide...

Jun 11, 2014, 08:00 ET
Eli Lilly and Company logo. (PRNewsFoto, Eli Lilly and Company)

Lilly Announces Top-Line Results Of Phase III Hepatocellular Carcinoma Trial

 Eli Lilly and Company (NYSE: LLY) today announced that the Phase III REACH trial of CYRAMZA™ (ramucirumab) in patients with...

Jun 09, 2014, 10:00 ET
Eli Lilly and Company logo. (PRNewsFoto, Eli Lilly and Company)

Lilly to Participate in Goldman Sachs Global Healthcare Conference

Eli Lilly and Company (NYSE: LLY) will attend the Goldman Sachs 35th Annual Global Healthcare Conference on Wednesday, June 11th, 2014. David...

Jun 09, 2014, 09:00 ET
Eli Lilly and Company logo. (PRNewsFoto, Eli Lilly and Company)

Lilly to Present New Clinical Data from Diabetes Portfolio with 76 Abstracts at the 74th American Diabetes Association Scientific Sessions®

 Eli Lilly and Company (NYSE: LLY) today announced 76 abstracts to be presented June 13-17 at the 74th American Diabetes Association Scientific...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

Research and Markets
Analysts Review
ReportBuyer